Precision BioSciences gains rights to MaxCyte’s cell engineering technology to develop next-generation, oncology-focused, cell therapies with Precision’s ARCUS® genome-editing technology DURHAM, NC, and GAITHERSBURG, MD – Precision BioSciences (Precision) and MaxCyte today announced they have entered into a non-exclusive, clinical and commercial license agreement that will allow Precision to use MaxCyte’s Flow Electroporation® technologies to robustly […]
Low Profile or PCR strips, also known as “0.1 ml“ PCR strips, are required for so-called “Fast PCR Thermocyclers“ (0.1 ml block format). Due to the Low Profile design or shorter size, respectively, there is less room for the liquid PCR mixture to transfer into the gas phase when it is being heated. During PCR, […]
BioLegend partners on TotalSeq™ antibodies to boost single cell surface protein profiling within VIB
BioLegend, a world-class antibody provider, announced today a new partnership with VIB, a leading life science research institute in Flanders (Belgium), to evaluate and implement the TotalSeqTM antibodies for next-generation multi-omics by the combining single cell transcriptomics with single cell proteomics profiling. Early this year, an exclusive license agreement was announced between BioLegend and the […]
inDrop™ System selected to generate predictive multi-omic clinical research data for undiagnosed conditions with immune dysfunction CAMBRIDGE, Mass., and MOUNTAIN VIEW, Calif. – 1CellBio Inc., a leading single-cell analysis company serving the biomedical research community, today announced a partnership agreement with the Open Medicine Institute (OMI), a leading independent precision medicine clinical and research organization. […]
HERCULES, Calif.–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that the company has been awarded a contract for iQ-Check real-time PCR pathogen detection test kits and the iQ-Check Prep Automation System from the United States Department of Agriculture’s Food Safety and Inspection Service […]
SAN FRANCISCO–Trace Genomics®, a San Francisco Bay area startup developing revolutionary, AI-enabled diagnostic tools for farmers to increase yields and reduce costs, has closed a $13 million Series A round. Trace Genomics has launched the first scalable soil microbiome test to enable the early prediction of soil diseases, soil health and crop quality. Every tablespoon […]
QuickGene-Auto12S/QuickGene-Auto24S are benchtop device for automated DNA/RNA isolation. It can isolate high-yield and high-purity of DNA/RNA due to the patented porous membrane. Specific reagent kits are pre-filled reagent strips. These strips are supplied in a sealed condition with required reagents for isolation in one strip to reduce the contamination risk. Key Features Specification Consumables *Warning […]
First end-to-end workflow for multi-species screening and identification BASINGSTOKE, England — Thermo Fisher Scientific announced the introduction of a new, complete next generation sequencing (NGS) workflow for multi-species screening and identification for food authenticity. This comes after Oxoid Ltd. (a part of Thermo Fisher Scientific) and SGS MOLECULAR, S.A. signed a global co-marketing and distribution agreement that […]
–CRISPR Therapeutics Gains Additional Rights to MaxCyte’s Cell Engineering Technology to Develop CRISPR/Cas9-Based Cell Therapies in Immuno-Oncology– ZUG, SWITZERLAND, CAMBRIDGE, MASS. and GAITHERSBURG, MD – CRISPR Therapeutics (NASDAQ:CRSP) and MaxCyte today announced the expansion of their existing relationship by entering into a non-exclusive commercial license agreement that will allow CRISPR Therapeutics to deploy MaxCyte’s Flow Electroporation® […]
Company creates U.S. subsidiary and adds Dr. Jeffrey Jeddeloh as VP of Business Development, Commercial Strategy, Dr. Stephen Macevicz as VP of IP and Dr. Christine Peponnet as VP of Technology Development. PARIS and CAMBRIDGE, Mass. – DNA Script, the global leader in the development of enzymatic DNA synthesis, today announced the creation of DNA Script […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
